A detailed history of Graham Capital Management, L.P. transactions in Uni Qure N.V. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 20,858 shares of QURE stock, worth $154,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,858
Holding current value
$154,974
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.39 - $5.43 $91,566 - $113,258
20,858 New
20,858 $93,000
Q2 2023

Aug 14, 2023

BUY
$11.12 - $22.2 $210,890 - $421,023
18,965 New
18,965 $217,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $347M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.